| Name | CCK-B Receptor Antagonist 2 |
|---|---|
| Synonyms |
Urea, N-(3-aminophenyl)-N'-[(3R)-1-(3,3-dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazin-3-yl]
CCK B Rector Antagonist 2,CCKB Rector Antagonist 2 CCK-B Rector Antagonist 2 |
| Description | CCK-B Receptor Antagonist 2, compound 15b, is a potent and orally active Gastrin/CCK-B antagonist with an IC50 value of 0.43 nM. CCK-B Receptor Antagonist 2 also inhibits gastrin/CCK-A activity with an IC50 of 1.82 μM[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.43 nM (Gastrin/CCK-B); 1.82 μM (Gastrin/CCK-A)[1] |
| In Vivo | CCK-B Receptor Antagonist 2 (0.1 μmol/kg; intravenous injection) has an inhibition effect on pentagastrin-induced gastric acid secretion in anethsetized rats with an ED50 of 8.3 nmol/kg[1]. |
| References |
| Molecular Formula | C27H28N6O3 |
|---|---|
| Molecular Weight | 484.55 |